DK0594570T3 - Colestyraminholdige mikrotabletter som lipidsænkende middel - Google Patents

Colestyraminholdige mikrotabletter som lipidsænkende middel

Info

Publication number
DK0594570T3
DK0594570T3 DK90913811.7T DK90913811T DK0594570T3 DK 0594570 T3 DK0594570 T3 DK 0594570T3 DK 90913811 T DK90913811 T DK 90913811T DK 0594570 T3 DK0594570 T3 DK 0594570T3
Authority
DK
Denmark
Prior art keywords
colestyramine
lipid
lowering agent
containing micro
micro tablets
Prior art date
Application number
DK90913811.7T
Other languages
Danish (da)
English (en)
Inventor
Thomas Moest
Erwin Spiegel
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/de
Priority claimed from DE3930168A external-priority patent/DE3930168A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0594570T3 publication Critical patent/DK0594570T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Laminated Bodies (AREA)
  • Sealing Battery Cases Or Jackets (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90913811.7T 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel DK0594570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19893930206 DE3930206A1 (de) 1989-09-09 1989-09-09 Pharmazeutische erzeugnisse
DE3930168A DE3930168A1 (de) 1989-09-09 1989-09-09 Verbesserte verabreichungsform fuer colestyramin

Publications (1)

Publication Number Publication Date
DK0594570T3 true DK0594570T3 (da) 1995-09-11

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90913811.7T DK0594570T3 (da) 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel

Country Status (10)

Country Link
EP (1) EP0594570B1 (fr)
JP (1) JPH05500213A (fr)
KR (1) KR920703071A (fr)
AT (1) ATE125448T1 (fr)
AU (1) AU638493B2 (fr)
CA (1) CA2065151A1 (fr)
DE (1) DE59009451D1 (fr)
DK (1) DK0594570T3 (fr)
IL (1) IL95574A (fr)
WO (1) WO1991003249A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
ES2274013T3 (es) 2001-01-26 2007-05-16 Schering Corporation Combinaciones de activador(es) del receptor activado por el proliferador de los peroxisomas (ppar) e inhibidor(es)m de la absorcion de estelores y tratamientos para trastornos vasculares.
PT1355644E (pt) 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7560449B2 (en) 2002-11-06 2009-07-14 Schering Corporation Methods and therapeutic combinations for the treatment of demyelination
EP1606287B1 (fr) 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Composés d'azetidinone substitués, formulations et utilisations de ceux-ci pour traiter l'hypercholestérolémie
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081003A1 (fr) 2003-03-07 2004-09-23 Schering Corporation Composes d'azetidinone substitues, leurs formulations et leur utilisation pour traiter l'hypercholesterolemie
EP3777864A1 (fr) 2010-11-04 2021-02-17 Albireo AB Inhibiteurs ibat pour le traitement de maladies du foie
WO2015199147A1 (fr) 2014-06-25 2015-12-30 味の素株式会社 Préparation pharmaceutique solide, et procédé d'inhibition ou d'atténuation de coloration de celle-ci
EP3012252A1 (fr) 2014-10-24 2016-04-27 Ferring BV Formes crystallines d'Elobixibat
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
WO2017138878A1 (fr) * 2016-02-09 2017-08-17 Albireo Ab Formulation orale de cholestyramine et utilisation associée
EP3413875B1 (fr) * 2016-02-09 2020-01-29 Albireo AB Pastilles de cholestyramine et procédés de préparation associés
WO2019032027A1 (fr) * 2017-08-09 2019-02-14 Albireo Ab Pastilles de cholestyramine, formulations orales de cholestyramine et leur utilisation
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
CA3100113A1 (fr) 2018-06-05 2019-12-12 Albireo Ab Composes de benzothia(di)azepine et leur utilisation en tant que modulateurs de l'acide biliaire
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
IL279464B2 (en) 2018-06-20 2025-12-01 Albireo Ab Pharmaceutical formulation of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
SMT202300020T1 (it) 2019-02-06 2023-03-17 Albireo Ab Composti di benzotiadiazepine e loro uso come modulatori degli acidi biliari
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
BR112022010505A2 (pt) 2019-12-04 2022-09-06 Albireo Ab Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar
EP4069247B1 (fr) 2019-12-04 2025-03-26 Albireo AB Composés de benzothiadiazépine et leur utilisation en tant que modulateurs de l'acide biliaire
EP4069359B1 (fr) 2019-12-04 2024-01-03 Albireo AB Composés de benzothia(di)azepine et leur utilisation en tant que modulateurs d'acide biliaire
CN114761080B (zh) 2019-12-04 2024-07-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
ES3002777T3 (en) 2020-08-03 2025-03-07 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
KR20230106651A (ko) 2020-11-12 2023-07-13 알비레오 에이비 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트
CN116583504A (zh) 2020-12-04 2023-08-11 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
DE3572440D1 (en) 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
CA1313135C (fr) * 1987-02-09 1993-01-26 The Dow Chemical Company Composition de cholestyramine et procede pour sa preparation
DE3869590D1 (de) * 1987-12-29 1992-04-30 Procter & Gamble Mischung zur behandlung von hypercholesterolemie.
DE3808191C2 (de) 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
EP0594570A1 (fr) 1994-05-04
AU6405790A (en) 1991-04-08
JPH05500213A (ja) 1993-01-21
CA2065151A1 (fr) 1991-03-10
EP0594570B1 (fr) 1995-07-26
ATE125448T1 (de) 1995-08-15
IL95574A0 (en) 1991-06-30
DE59009451D1 (de) 1995-08-31
AU638493B2 (en) 1993-07-01
KR920703071A (ko) 1992-12-17
IL95574A (en) 1994-11-11
WO1991003249A1 (fr) 1991-03-21

Similar Documents

Publication Publication Date Title
DK0594570T3 (da) Colestyraminholdige mikrotabletter som lipidsænkende middel
FI924553A0 (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
NO900227L (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
FI904482A0 (fi) Gummikomposition som innehaoller dispergerade poerosa paerlor innehaollande aktiva bestaondsdelar foer tuggummi och foerfarande.
NL960002I2 (nl) Nieuwe taxolderivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze bevatten.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI921279L (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
IT1233330B (it) Lampada da tavolo.
FI900762A0 (fi) Tris-hydroximetylalkanestrar som fettimitationer med laog kalorihalt.
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
NO963497D0 (no) Fibrin-spesifikt antistoff for anvendelse som et antitrombotisk middel
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
FI892214L (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI895483L (fi) Som slaglod anvaendbara kopparblandningar.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
DK0577745T3 (da) Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler.
FI893225L (fi) Behandling av gaser som innehaoller halogenfoereningar.
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
NO901169D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
FI922124L (fi) Azabicykloamider och -estrar som 5-ht3-receptorantagonister.
DE69017188D1 (de) Projektionsanzeigevorrichtung.
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
ATE80143T1 (de) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
FI903111A0 (fi) Bis (benzylpyrrolidin) derivat som dopaminantagonister.